Published in Arthritis Rheum on May 01, 2003
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia. Leuk Lymphoma (2012) 1.57
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood (2012) 1.23
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias. Clin Cancer Res (2012) 1.20
High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood (2002) 1.17
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. Biol Blood Marrow Transplant (2013) 1.13
American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Oncol Pract (2010) 1.00
Renal cell carcinoma induced Coombs negative autoimmune hemolytic anemia and severe thrombocytopenia responsive to nephrectomy. J Urol (2002) 0.97
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Haematologica (2012) 0.90
High-dose cyclophosphamide as salvage therapy for severe aplastic anemia. Exp Hematol (2004) 0.88
Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen. Ann Diagn Pathol (2007) 0.88
Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant (2013) 0.87
The role of growth factors in the activity of pharmacological differentiation agents. Cell Growth Differ (2002) 0.87
Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation. Am J Hematol (2002) 0.86
High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst (2005) 0.85
A roadmap for education to improve the quality of care in gout. Curr Opin Rheumatol (2010) 0.84
Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group. Leuk Res (2004) 0.83
Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplant. Transplantation (2004) 0.82
Human endogenous retrovirus (HERV-K) particles in megakaryocytes cultured from essential thrombocythemia peripheral blood stem cells. Exp Hematol (2004) 0.82
Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling. Transfusion (2012) 0.81
High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve (2006) 0.80
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance. Mult Scler (2011) 0.78
Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma. Leuk Lymphoma (2013) 0.77
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma. Clin Adv Hematol Oncol (2005) 0.77
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias. Br J Haematol (2012) 0.75
Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma. Ann Hematol (2014) 0.75
High-dose chemotherapy and multiple sclerosis. Curr Opin Oncol (2011) 0.75
Thrombotic thrombocytopenic purpura induced by cyclosporin a after allogeneic bone marrow transplantation treated by red blood cell exchange transfusion: a case report. Am J Hematol (2005) 0.75
Mycophenolate mofetil treatment of steroid-resistant idiopathic sclerosing orbital inflammation. Clin Experiment Ophthalmol (2011) 0.75
Granulocytic sarcoma presenting as bilateral adrenal masses. Am J Hematol (2005) 0.75
Malignant pericardial effusion--an uncommon complication of multiple myeloma: case report. Heart Surg Forum (2005) 0.75
Quality of life after high-dose cyclophosphamide in patients with severe autoimmune diseases. J Eval Clin Pract (2005) 0.75